ATE403153T1 - Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Info

Publication number
ATE403153T1
ATE403153T1 AT01978211T AT01978211T ATE403153T1 AT E403153 T1 ATE403153 T1 AT E403153T1 AT 01978211 T AT01978211 T AT 01978211T AT 01978211 T AT01978211 T AT 01978211T AT E403153 T1 ATE403153 T1 AT E403153T1
Authority
AT
Austria
Prior art keywords
biological cell
test
related biological
body fluid
fluid sample
Prior art date
Application number
AT01978211T
Other languages
English (en)
Inventor
Michael Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE403153T1 publication Critical patent/ATE403153T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
    • G01N2333/135—Respiratory syncytial virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01978211T 2000-10-17 2001-10-12 Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe ATE403153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001549 2000-10-17
US24213200P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE403153T1 true ATE403153T1 (de) 2008-08-15

Family

ID=26068896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978211T ATE403153T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Country Status (9)

Country Link
US (1) US6790611B2 (de)
EP (1) EP1340086B1 (de)
JP (1) JP2004511807A (de)
AT (1) ATE403153T1 (de)
AU (2) AU1038402A (de)
CA (1) CA2463678A1 (de)
DE (1) DE60135147D1 (de)
DK (1) DK1340086T3 (de)
WO (1) WO2002033417A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004511802A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中の炎症の指標の直接的検出のためのアッセイ
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
US20090314946A1 (en) * 2002-08-27 2009-12-24 Kimberly-Clark Worldwide, Inc. Membrane-Based Assay Devices that Utilize Time-Resolved Fluorescence
EP1620728A4 (de) * 2003-05-02 2006-07-05 Access Bio Inc Chromatographisches assay-sytem
WO2005031355A1 (en) * 2003-09-22 2005-04-07 Quidel Corporation Devices for the detection of multiple analytes in a sample
US20060046310A1 (en) * 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ES2536915T5 (es) 2005-04-04 2023-03-01 Biogen Ma Inc Métodos y productos para evaluar una respuesta inmunitaria a una proteína terapéutica
HUE047230T2 (hu) 2006-02-28 2020-04-28 Biogen Ma Inc Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei
EP4582099A3 (de) 2006-03-03 2025-10-01 Biogen MA Inc. Verfahren zur behandlung von entzündungs- und autoimmunerkrankungen mit natalizumab
GB0612825D0 (en) * 2006-06-28 2006-08-09 Iti Scotland Ltd Analyte detection
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
WO2008085963A1 (en) * 2007-01-05 2008-07-17 University Of Florida Research Foundation, Inc. Materials and methods for the detection, prevention and treatment of autoimmune disease
US8865454B2 (en) * 2007-03-22 2014-10-21 Scandinavian Micro Biodevices Aps Flow through system, flow through device and a method of performing a test
JP5214723B2 (ja) 2007-04-30 2013-06-19 ナノゲン・インコーポレイテッド 多分析物アッセイ
WO2008154813A1 (fr) 2007-06-15 2008-12-24 Xiamen University Anticorps monoclonaux se liant à l'hémagglutinine du virus de la grippe aviaire du sous type h5 et ses utilisations
US20090208975A1 (en) * 2007-12-13 2009-08-20 Beckman Coulter, Inc. Device and methods for detecting a target cell
US9285361B2 (en) * 2008-07-03 2016-03-15 Johnson & Johnson Ab Method for the analysis of circulating antibodies
JP5575377B2 (ja) * 2008-07-18 2014-08-20 シスメックス株式会社 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
ES2666372T3 (es) 2009-10-11 2018-05-04 Biogen Ma Inc. Ensayos relacionados con anti-VLA-4
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
EP4152004B9 (de) 2010-01-11 2025-04-09 Biogen MA Inc. Assay für jc-viren-antikörper
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
LT3575792T (lt) 2011-05-31 2023-03-10 Biogen Ma Inc. Pdl rizikos vertinimo būdas
CL2011003002A1 (es) 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.
CN104813166B (zh) * 2012-09-28 2016-05-04 积水医疗株式会社 用于测量非稀释类型免疫层析法试剂中的样品的添加剂
BR112015014232A2 (pt) * 2012-12-20 2017-07-11 Novartis Ag lesão renal aguda
WO2014193804A1 (en) 2013-05-28 2014-12-04 Biogen Idec Ma Inc. Method of assessing risk of pml
ES2683169T3 (es) * 2013-06-21 2018-09-25 Alfresa Pharma Corporation Dispositivo de inmunocromatografía para detectar el VRS
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
BR112016022829B1 (pt) 2014-04-02 2022-03-03 Chembio Diagnostic Systems, Inc Dispositivo de teste para determinar a presença de um primeiro ligante em uma amostra líquida, e método para testar uma amostra quanto à presença de um primeiro ligante
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
JP2016164553A (ja) * 2015-02-27 2016-09-08 株式会社リコー 標的検査装置、標的検査キット、標的検査方法、転写媒体、及び標的検査装置の製造方法
US9867250B1 (en) 2015-04-20 2018-01-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona System having a configurable pico-second pulsed LED driver circuit and photomultiplier tube biasing and gating circuits for real-time, time-resolved transient recording of fluorescence
DK3785799T3 (da) 2015-08-06 2023-03-06 Lia Diagnostics Inc Fremstillingsfremgangsmåder til vanddispergerbare assays
WO2020006494A1 (en) 2018-06-29 2020-01-02 Fred Hutchinson Cancer Research Center Cell-stored barcoded deep mutational scanning libraries and uses of the same
CA3111336A1 (en) 2018-09-03 2020-03-12 Pontificia Universidad Catolica De Chile Specific monoclonal antibody against the n antigen of human respiratory syncytial virus (hrsv) useful for treating infection, detection thereof and diagnosis
US11590507B2 (en) * 2020-02-25 2023-02-28 Helixbind, Inc. Reagent carriers for fluidic systems
US20230116817A1 (en) * 2020-03-26 2023-04-13 Security Matters Ltd. Device and method for detection of viruses by xrf
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4663277A (en) * 1983-05-20 1987-05-05 Profile Diagnostic Sciences Inc. Virus detection method and materials
JPH05504617A (ja) 1989-06-06 1993-07-15 アンプコー・インコーポレーテッド 免疫検定診断用キット
CA2023850A1 (en) * 1989-09-28 1991-03-29 Randal A. Hoke Stabilizing reagent for membrane immunoassay
US5075078A (en) * 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
DK130991D0 (da) * 1991-07-04 1991-07-04 Immunodex K S Polymere konjugater
AU2392692A (en) * 1991-07-19 1993-02-23 Assay Research, Inc. Method and kit for measuring endogenous cytokines
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
CA2144043C (en) * 1992-09-16 2005-01-18 Dennis R. Burton Human neutralizing monoclonal antibodies to respiratory syncytial virus
US6077511A (en) * 1994-08-25 2000-06-20 Instituut Voor Dierhouderij En Diergezondheid Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection
US6083708A (en) * 1995-08-11 2000-07-04 Dade Behring Inc. Polypeptide: dendrimer complexes
AU7081796A (en) * 1995-10-03 1997-04-28 Universite De Montreal Diagnostic kit for bovine syncytial respiratory virus
JP3601972B2 (ja) * 1998-05-14 2004-12-15 松下電器産業株式会社 色素標識タンパク質複合体およびその製造方法
US6451980B1 (en) * 1997-02-26 2002-09-17 Ban-An Khaw Signal enhancement of bispecific antibody-polymer probe for immunoassay use
US7776542B1 (en) * 1997-08-04 2010-08-17 Advanced Life Science Institute Methods for the detection of hepatitis B and C viruses

Also Published As

Publication number Publication date
US6790611B2 (en) 2004-09-14
CA2463678A1 (en) 2002-04-25
EP1340086B1 (de) 2008-07-30
WO2002033417A1 (en) 2002-04-25
AU2002210384B2 (en) 2006-10-19
DE60135147D1 (de) 2008-09-11
DK1340086T3 (da) 2008-12-01
AU1038402A (en) 2002-04-29
EP1340086A1 (de) 2003-09-03
US20020081573A1 (en) 2002-06-27
JP2004511807A (ja) 2004-04-15

Similar Documents

Publication Publication Date Title
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
AU2003243558A8 (en) Test strip for detection of analyte and methods of use
EP0805215A3 (de) Diagnostische Methoden und Proben
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
WO2001038873A3 (en) Devices and methods for detecting analytes using electrosensor having capture reagent
WO2002033410A3 (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
JP2004503760A5 (de)
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
AU6775201A (en) Improved capture and detection of target nucleic acid in dipstick assays
BR0206145A (pt) Sistema de teste indicador com tira reagente para uso em lìquidos para a detecção e/ou determinação de sequências especìficas de ácido nucléico
DE69737628D1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
DE60225802D1 (de) Verfahren und gerät zum nachweis des gesamten proteingehaltes bei niedrigen ph-werten
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
DE60038557D1 (en) Assay
WO2002004122A3 (en) Improved stability of hybridisation interactions in dipstick assays
DE50203136D1 (de) Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen
GB0304832D0 (en) Assay method
CA2671474A1 (en) A method for detecting human parvovirus antigen
WO2002064823A3 (de) Verfahren zum nachweis und/oder zur quantifizierung eines analyten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties